Three countries' experience with Norplant introduction

Health Policy and Planning

Volumn 12, Issue 3, 1997, Pages 199-213

  Hardee, Karen ^a   Balogh, Sandor ^a   Villinskp, Michele T ^b  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL;

BANGLADESH; DRUG COST; DRUG SAFETY; FAMILY PLANNING; FEMALE; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; INDONESIA; MENSTRUATION DISORDER; PAIN; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT INFORMATION; REVIEW; SKIN SCAR; UNITED STATES;

AMERICAS; ASIA; BANGLADESH; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, PROGESTIN; CONTRACEPTIVE IMPLANTS; CONTRACEPTIVE METHODS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; FAMILY PLANNING; INDONESIA; LEVONORGESTREL; NORTH AMERICA; NORTHERN AMERICA; SOUTHEASTERN ASIA; SOUTHERN ASIA; UNITED STATES;

ADOLESCENT; ADULT; BANGLADESH; CONTRACEPTIVE AGENTS, FEMALE; DRUG INDUSTRY; FAMILY PLANNING POLICY; FEMALE; GOVERNMENT PROGRAMS; HUMANS; INDONESIA; INTERNATIONAL COOPERATION; LEVONORGESTREL; LIABILITY, LEGAL; MALE; PATIENT EDUCATION; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 0030809978     PISSN: 02681080     EISSN: None     Source Type: Journal    
DOI: 10.1093/heapol/12.3.199     Document Type: Review

References (117)

1. Affandi B, Santoso SS, Djajadilaga, Hadisaputra W, Moeloek FA et al. 1987. Pregnancy after removal of Norplant implants contraceptive. Contraception 36(2): 203-9.
2. Akhter F. 1990. Violation of ethics in research: Norplant is not being removed. Resistance Network Newsletter. March.
3. Akhter F, Karka M, Dos Reis A. 1991. Letter on Norplant to Boston Women's Health Book Collective. October 10.
4. Akhter F. 1995. Resisting Norplant. Dhaka: Narigrantha Prabartana.
5. Akhter H, Dunson TR, Amatya RN, Begum K, Chowdhury T et al. 1993. A five-year clinical evaluation of NORPLANT contraceptive subdermal implants in Bangladeshi acceptors. Contraception 47: 469-582.
6. Akhter HH. 1990. Naripakkha is not correct. Holiday. August 31.
7. Akhter HH, Ahmed YH. 1992. An Overview of the Norplant Pre-Introductory Pilot Phase (NPIPP) Project. Paper presented at the Dissemination Workshop for the Study of the Quality of Norplant Services in Bangladesh, Dhaka, October 27.
8. Akhter HH, Rasul KG, Rahman MH, Kabir AKMM, Khan MKMKZ. 1996. A Report on Norplant Pre-Introductory Pilot Phase in Bangladesh. Dhaka: BIRPERHT.
9. Ahmed YH. 1990. Women in development: need for pragmatic thinking. The Bangladesh Observer. September 24.
10. Alvarez-Sanchez F, Brache V, Faundes A. 1988. The Clinical Performance of NORPLANT Implants Over Time: A Comparison of Two Cohorts. Studies in Family Planning 19(2): 18-21.
11. Antarsh L. 1992. A patchwork of funding sources for Norplant in the U.S. AVSC News 30(3): 1-2.
12. Arshat H, Rachagan SP, Kwa Siew Kim, Ang Eng Suan, Karim HA, Ismail MT. 1990. A study of the acceptability and effectiveness of Norplant contraceptive implants in Kuala Lumpur, Malaysia. Malaysian Journal of Reproductive Health 8(1): 21-9.
13. Azim T, Huq N. 1990. Family planning at the cost of women's health. Holiday July 27.
14. Balogh SA, Ladipo OA, Ekwempu CC, Diejomaoh M, Fakeye O et al. 1992. Three year experience with Norplant contraceptive implants in Nigeria. The British Journal of Family Planning 17(4): 103-7.
15. Bangladesh Fourth Population and Health Project Report of the Preparatory Review Group for the Midterm Review. 1995. Final Report for the World Bank.
16. Barnett B. 1995. Norplant Removals Vital to Quality Care. Network 15(4), June.
17. Basnayake S, Thapa S, Balogh S. 1988. Evaluation of safety, efficacy, and acceptability of Norplant implants in Sri Lanka. Studies in Family Planning 19(1): 34-7.
18. Beilenson PL, Miola ES, Farmer M. 1995. Politics and practice: introducing Norplant into a school-based health center in Baltimore. American Journal of Public Health 85(3): 309-11.
19. Birth Control: Ending Child Labour. 1993. The Economist. January 30: 26-7.
20. BKKBN 1994. Training and Development Center for Biomedical and Human Reproduction. A Situation Analysis of the Government Run Service Delivery Points for Family Planning in Indonesia. Jakarta: BKKBN
21. BKKBN, BKS PENFIN and The Population Council. 1991. Norplant Users Tracking. Notification Systems for Five Year Removals and Removal Service Delivery in Indonesia. Proposal for Operations Research. Jakarta: BKKBN.
22. BKKBN and Population Council. 1992. Norplant Use-Dynamics Diagnostic Study. Jakarta: BKKBN and Population Council. H Kasidi and P Miller.
23. Bratakoesoema DS, Djamal FR, Bachtiar H, Masrul, Azwar NB et al. 1993. The Norplant Contraceptive: An Indonesian Experience. The Population Council Operations Research Working Papers, No. 2. Islamabad: The Population Council.
24. Central Bureau of Statistics, National Family Planning Coordinating Board, Ministry of Health and Macro International Inc. 1995. Indonesian Demographic and Health Survey. Preliminary Report. Jakarta: Central Bureau of Statistics, and Calverton, MD: Macro International Inc.
25. Chauls D. 1994. Is the Indonesian Family Planning Program Coercive? Paper presented at the Annual Conference of the National Council for International Health. Washington, DC: June.
26. Cleland J, Mauldin P. 1991. The promotion of family planning by financial payments: the case of Bangladesh. Studies in Family Planning (22)1: 1-18.
27. Clinics Struggle with High Norplant Costs. 1993. Family Planning World. November/December: 23.
28. Cowley G. 1995. The Norplant Backlash. Newsweek November 27: 52.
29. Curtin L, Johnson CN, Kantner AB, Papilaya A. 1992. Indonesia's National Family Planning Program: Ingredients for Success. Population Technical Assistance Project. Occasional Paper No. 6.
30. Darney PD, Atkinson E, Tanner S, MacPherson S, Hellerstein S, Alvarado A. 1990. Acceptance and perceptions of Norplant among users in San Fransisco. Studies in Family Planning 21(3): 152-60.
31. Diadhiou F, Nare C, Paye EHO, Sangare M, Gueye MB et al. 1993. Etude de la Perspective de la Cliente sur L'Introduction du Norplant au Senegal. Final Report. Dakar, Senegal: Hopital Aristide le Dantec Clinique Gyneco-Obstetrique and Family Health International.
32. Doucoure A, Tandia D, Sangare M. 1995. Program Evaluation of Norplant Introduction in Mali. Final Report. Bamako: Division Sante Familiale et Communautaire, and Research Triangle Park: Family Health International.
33. Family Development Services and Research (FDSR). 1986. Motivation and Decision-Making in Voluntary Sterilization: A Focus Group Study. Dhaka: Final Report.
34. Fisher A, Diaz S, Herrin A, Prihartono J. 1995. Report on Norplant Implants in Indonesia. Asia and Near East Operations Research and Technical Assistance Project. New York: The Population Council.
35. Forrest JD, Kaeser L. 1993. Questions of balance: issues emerging from the introduction of the hormonal implant. Family Planning Perspectives 25(3): 127-32.
36. Frank ML, Poindexter III AN, Cornin LM, Cox CA, Bateman L. 1993. One-year experience with subdermal contraceptive implants in the United States. Contraception 48, September: 229-43.
37. Frost J. 1995. The Introduction of Norplant. A Summary of the Legislative, Legal and Service Delivery Issues. Presentation made at the Annual Meetings of the Population Association of America. San Fransisco, April 5-8.
38. Frost J. 1994. The availability and accessibility of the contraceptive implant from family planning agencies in the United States: 1991-1992. Family Planning Perspectives 26(1): 4-10.
39. Goodman E. 1991. A Leap from Contraception to Coercion. The Boston Globe February 19.
40. Gu S, Du M, Yuan DY, Zhang LD, Xu MF et al. 1988. A two-year study of acceptability, side effects, and effectiveness of Norplant and Norplant-2 implants in the People's Republic of China. Contraception 38(6): 641-57.
41. Haider SJ, Streatfield K, Karim MA. 1995. Comprehensive Guidebook to the Bangladesh Family Planning-MCH Program. Dhaka: Research Evaluation Associates for Development, The Population Council and Ministry of Health and Family Welfare.
42. Hardee K, Barkat-e-Khuda, Kamal GM, Rahman APMS, McMahan J. 1994. Contraceptive implant users and their access to removal services in Bangladesh. Family Planning Perspectives 20(2): 59-65.
43. Hardon A. 1992. Norplant: Conflicting Views on its Safety and Acceptability. In: Holmes HB (ed). Issues in Reproductive Technology I: An Anthology. New York: Garland Publishing.
44. Hardy E, Goodson P, De Souza TR, Rodriguez CM. 1991. Factors associated with the acceptance of Norplant or IUD among women with similar socio-demographic characteristics. Advances in Contraception 7(1): 95-105.
45. Hartman B, Standing H. 1985. Food, Saris and Sterilization. London: Bangladesh International Action Group.
46. Hassan EO, Kafafi L, El Husseini M, Hardee-Cleaveland K, Potter L. 1992. The acceptability of Norplant in Egypt. Advances in Contraception 8(4): 331-48.
47. Hatcher RA, Miller M. 1991. Overall experience with Norplant positive for clients, clinicians. Contraceptive Technology Update 12(11): 179-81.
48. Henshaw SK, Torres A. 1994. Family planning agencies: services, policies and funding. Family Planning Perspectives 26(2): 52-9.
49. Hull, Valerie. 1995. Personal communication, Jakarta, Indonesia.
50. International Planned Parenthood Federation (IPPF), International Medical Advisory Panel. 1985. Statement on Norplant Subdermal Contraceptive Implant System. IPPF Medical Bulletin 19(5): 1-2.
51. International Planned Parenthood Federation (IPPF), International Medical Advisory Panel. 1995. Statement on Norplant Subdermal Contraceptive Implant System. London: IPPF.
52. Kaeser L. 1994. Public funding and policies for provision of the contraceptive implant, fiscal year 1992. Family Planning Perspectives 26(1): 11-16.
53. Kalmuss D, Davidson A, Cushman L. 1995. The Determinants of Norplant Use. Paper presented at the Annual Meetings of the Population Association of America. San Fransisco, April 5-8.
54. Kamal GM, Hardee-Cleaveland K, Barkat-E-Khuda. 1991. The Quality of Norplant Services In Bangladesh. Final Report. Dhaka: Associates for Community and Population Research.
55. Kantrowitz B, Wingert P. 1993. The Norplant Debate. Newsweek February 15: 37-41.
56. Keller S. 1990. United States Agency for International Development/Dhaka Trip Report. Unpublished. August 28.
57. Kocher J. 1996. Personal communication, North Carolina. March.
58. Kolata G. 1995. Will the Lawyers Kill Off Norplant? The New York Times. May 28: 1, 5.
59. Krueger S, Dunson TR, Amatya RN. 1994. Norplant contraception acceptability among women in five Asian countries. Contraception 50 October: 349-61.
60. Larimer T. 1993. Arming Girls against Pregnancy. USA Weekend February 26-28: 24.
61. Larson A, Mitra SN. 1992. Family planning in Bangladesh: an unlikely success story. International Family Planning Perspectives 18(4): 123-9.
62. Lewin T. 1994. 'Dream' Contraceptive's Nightmare. The New York Times July 8: A10.
63. Lewin T. 1991. 5-Year Contraceptive Seems Headed for Wide Use. The New York Times November 29.
64. Lopez G, Rodriguez A, Rengifo J, Sivin I. 1986. Two-year prospective study in Colombia of Norplant implants. Obstetrics and Gynecology 68(2): 204-8.
65. Lubis F. 1992. The Experience of Norplant Use in Indonesia. Paper presented to WHO Meeting on Women's Perspectives on the Introduction of Fertility Regulation Technologies. Manila, October 5-9.
66. Marangoni P, Cartagena S, Alvarado J, Diaz J, Faundes A. 1983. Norplant implants and the TCu200 IUD: a comparative study in Ecuador. Studies in Family Planning 14(6/7): 177-80.
67. McCauley AP, Geller JS. 1992. Decisions for Norplant Programs. Population Reports, Series K, No. 4. Baltimore: Johns Hopkins University, Population Information Program.
68. Meade D. 1996. Who Cares if a Third World Woman Dies? Daily Star February 5. Dhaka.
69. Mitra SN, Lerman C, Islam S, Cross AR, Shaha T. 1994. Bangladesh Demographic and Health Survey, 1993/4. Dhaka: Mitra and Associates, NIPORT, USAID and Macro International.
70. Noerpramana NP. 1991. The Norplant removal training and service at Dr Kariadi Hospital, Semarang, Indonesia. Advances in Contraception 7(4): 389-401.
71. Noerpramana NP, Rusbandi. 1993. Factors influencing attitudes about Norplant contraceptive subdermal implant. Advances in Contraception 9(3): 215-26.
72. Palstra E. 1996. Personal communication. North Carolina/ Washington. March.
73. Peterson LS. 1995. Contraceptive Use in the United States: 1982-90. Advance Data No. 260, February 14.
74. Pillsbury B. 1990. The Politics of Family Planning: Sterilization and Human Rights in Bangladesh. In: Handwerker WP (ed). Births and Power: Social Change and the Politics of Reproduction. Colorado: Westview Press.
75. The Population Council. 1990. Norplant Levonorgestrel Implants: A Summary of Scientific Data. New York: The Population Council.
76. Proceedings of Workshop on Implementation of Large Scale Norplant Programs Subsequent to Preintroduction/Clinical Trial Phase. 1990. Organized by JHPIEGO in collaboration with the Raden Saleh Klinik (University of Indonesia) and the BKKBN. Jakarta, Indonesia, December 10-14.
77. Prihartono J. 1993. Review of Existing Norplant Implant Acceptor Tracking System. Jakarta: Yayasan Kusuma Buana.
78. Rawlins W. 1993. Wake to Offer 'No-Baby' Implants After Births. Raleigh News and Observer May 27: 2B.
79. Rob, Ubaidur. 1996. Personal communication. North Carolina/ Dhaka. March.
80. Satayapan S, Kanchanasinith K, Varakamin S. 1983. Perceptions and acceptability of Norplant in Thailand. Studies in Family Planning 14(6/7): 170-6.
81. Segal SJ. 1983. The development of Norplant Implants. Studies in Family Planning 14(6/7): 159-63.
82. Sen G, Snow RC. 1994. Power and Decision. The Social Control of Reproduction. Cambridge: Harvard Series on Population and International Health.
83. Seymour J. 1993. When the Pill Gets Under Your Skin. New Scientist December: 22-24.
84. Shoupe D, Ballagh S, Mishell, Jr. DR. 1992. Bleeding Patterns in Norplant Contraceptive Implant Users. In: Alexander NJ, d'Arcangues C (eds). Steriod Hormones and Uterine Bleeding. Washington DC: AAAS Press.
85. Singh K, Viegas OAC, Fong YF, Ratnam SS. 1992. Acceptability of Norplant implants for fertility regulation in Singapore. Contraception 45(1): 39-47.
86. Sivin I. 1993. Another look at the Dalkon Shield: meta-analysis underscores its problems. Contraception 48(1): 1-12.
87. Sivin I. 1988. International experience with Norplant and Norplant-2 contraceptives. Studies in Family Planning 19(2): 81-94.
88. Sivin I, Alvarez-Sanchez F, Diaz S, Holma P, Coutinho E et al. 1983. Three-year experience with Norplant Subdermal Contraception. Fertility and Sterility 39(6): 799-808.
89. Smyth I. 1991. The Indonesian Family Planning Programme: a success story for women? Development and Change 22(4): 781-805.
90. Soni V. 1984. The Development and Current Organization of the Family Planning Programme. In: Dyson T, Cook N (eds). India's Demography: Essays on the Contemporary Population. New Delhi: South Asian Publishers Pvt. Ltd.
91. Sobol RB. 1991. Bending the Law: The Story of the Dalkon Shield Bankruptcy. Chicago: University of Illinois Press.
92. Spicehandler J. 1988. Norplant Introduction: A Management Perspective. In: Segal S, Tsui AO, Rogers S (eds). Demographic and Programmatic Consequences of Contraceptive Innovations. New York: Plenum Press. Pp. 199-226.
93. Spicehandler J, Simmons R. 1994. Expanding Family Planning Options. Research on the Introduction and Transfer of Technologies for Fertility Regulation. Geneva: WHO/ HRP/ITT/94.1.
94. Studies in Family Planning Special Issue on Norplant. 1983. Studies in Family Planning 14(6/7).
95. Supply of Birth Control Device Not Meeting NC Demand. 1991. Durham Herald Sun November 4.
96. Talan J. 1995. The Norplant Controversy. Glamour April: 66-8.
97. Tan A, Mahdar E, Djamal FR, Bachtier H, Tuladhar J, Hoesni RHM. 1995. Improvements in Knowledge of Norplant Implant Acceptors: An Intervention Study in West Sumatra and West Java. Jakarta: Padjadjaran University (Bandung), Andalas University (Padang), National Family Planning Coordinating Board (BKKBN), and the Population Council.
98. Tanfer K. 1994. Knowledge, attitudes and intentions of American women regarding the hormonal implant. Family Planning Perspectives 26(2): 60-5.
99. Trussell J, Levegue JA, Koenis JD, London R, Borden S et al. 1995. The economic value of contraception: a comparison of 15 methods. American Journal of Public Health 85(4): 494-503.
100. UBINIG. 1991. The price of Norplant is TK. 2000! You cannot remove it: clients are refused removal in Norplant trial in Bangladesh. Issues in Reproductive and Genetic Engineering 4(1): 45-6.
101. United States Agency for International Development (USAID), Bureau for Science and Technology, Office of Population. 1990.
102. Norplanl Introduction Strategy. Washington, DC: USAID. November.
103. Use-dynamics study in Indonesia reveals need for better understanding of method by clients and service providers. Alternatives No. 1, April.
104. Walsh J, Belfield T. 1994. The introduction of Norplant implants into the United Kingdom. Reproductive Health Matters 3 May: 30-3.
105. Ward S, Poernomo Sigit Sidi I, Simmons R, Simmons G. 1990. Service Delivery Systems and Quality of Care in the Implementation of Norplant in Indonesia. Report prepared for the Population Council.
106. Washington Memo. 1993. Hearing Focuses on Price of Norplant; Wyeth Pledges Discount for Public Sector. No. 18, November 23: 3-4.
107. Westfall JM, Main DS. 1995. The contraceptive implant and the injectable: a comparison of costs. Family Planning Perspectives 27(1): 34-36.
108. Westhoff C, Marks F, Rosenfield A, Roig A, Nicholas A. 1994. Clinical and Legal Factors Influencing IUD Use in the United States. In: Bardin W, Mishell, Jr. DR. Proceedings from the Fourth International Conference on IUDs. Boston: Butterworth-Heinemann. pp. 100-8.
109. Where the Norplant Debate Hits Home. 1993. The New York Times. March 7.
110. Widyantoro N. 1994. The story of Norplant implants in Indonesia. Reproductive Health Matters 3: 20-8.
111. World Health Organization (WHO). 1985. Facts About an Implantable Contraceptive. Bulletin of the World Health Organization 63(3).
112. World Health Organization (WHO). 1990. Norplant Contraceptive Subdermal Implants. Managerial and Technical Guidelines. WHO/MCH/89.17. Geneva: World Health Organization.
113. World Health Organization (WHO). 1991. Creating Common Ground. Report of a meeting between women's health advocates and scientists. Geneva: WHO/HRP/ITT/91.
114. Woman Given Norplant Sentence. 1993. Family Planning World November/December: 13.
115. World Bank. 1990. Indonesia. Family Planning Perspectives in the 1990s. Washington DC: The World Bank.
116. Wyeth-Ayerst to Reduce US Price of Norplant Implants, but not until December 1995. 1994. Contraceptive Technology Update January: 1-3.
117. Zimmerman M, Haffey J, Crane E, Szumowski D, Alvarez F et al. 1990. Assessing the acceptability of Norplant implants in four countries: findings from focus group research. Studies in Family Planning 21(2): 92-103.